- Home
- CODA vs KPTI Comparison
CODA vs KPTI Comparison
Compare CODA & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CODA | KPTI |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.4M | 172.6M |
| IPO Year | 2007 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CODA | KPTI |
|---|---|---|
| Price | $11.40 | $5.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | 363.3K | ★ 1.2M |
| Earning Date | 03-17-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.62 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | $20,316,161.00 | ★ $146,067,000.00 |
| Revenue This Year | $18.28 | N/A |
| Revenue Next Year | $12.62 | $46.62 |
| P/E Ratio | $144.38 | ★ N/A |
| Revenue Growth | ★ 4.98 | 0.57 |
| 52 Week Low | $5.76 | $3.51 |
| 52 Week High | $18.00 | $10.99 |
Technical Indicators
Market Signals| Indicator | CODA | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 39.43 | 31.65 |
| Support Level | $7.47 | $5.60 |
| Resistance Level | $12.22 | $6.96 |
| Average True Range (ATR) | 1.03 | 0.88 |
| MACD | -0.39 | -0.38 |
| Stochastic Oscillator | 2.20 | 15.97 |
Price Performance
Historical ComparisonAbout CODA Coda Octopus Group Inc.
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).